Key Takeaways
- AI is accelerating analytical work in management consulting, reducing the time and cost traditionally spent on research and data‑crunching.
- A Deerborne Group study of genomics and precision diagnostics executives found a paradox: 62% reported lighter analytical workloads, yet 54% saw no meaningful gain in decision quality.
- The value of consulting is shifting from producing analysis to supplying deep domain expertise, sound judgment, and execution capability—areas where AI falls short.
- The Deerborne Group’s operator‑led, network‑based model leverages senior industry veterans rather than the traditional junior‑senior pyramid, positioning it to meet this new demand.
- For genomics and precision diagnostics, where commercial go‑to‑market decisions intertwine with clinical, regulatory, reimbursement, operational, and investor factors, expert judgment remains critical.
- Consulting firms that refocus their offerings on strategic insight, change management, and implementation will capture the next wave of value in an AI‑augmented landscape.
Introduction
Artificial intelligence is reshaping the economics of management consulting, a trend highlighted in recent research from The Deerborne Group. As AI tools automate data gathering, pattern recognition, and even preliminary recommendation engines, work that once required teams of junior analysts and weeks of effort can now be completed internally in hours or minutes. This shift raises a pivotal question for clients in precision diagnostics and life sciences: if analysis becomes faster and less expensive, where does consulting create value next?
Methodology
To answer that question, The Deerborne Group launched a pre‑ASCO 2026 executive pulse survey, followed by in‑depth qualitative interviews with senior diagnostics and life sciences executives attending the American Society of Clinical Oncology (ASCO) meeting. The combined approach captured both quantitative trends and nuanced perspectives on how AI is altering day‑to‑day workflows and strategic decision‑making processes within these highly specialized industries.
Findings: A Paradox of Efficiency and Decision Quality
The study revealed a striking paradox. “While 62% reported reduced analytical workload, 54% reported no meaningful improvement in decision quality,” the report notes. In other words, AI is successfully taking over the heavy lifting of data analysis, yet many executives feel that the quality of their strategic choices has not risen commensurately. This disconnect suggests that faster, cheaper analysis alone does not guarantee better outcomes; the missing ingredient appears to be the human ability to interpret, prioritize, and act on insights.
Executive Perspective on Value Shift
Jeffrey G. Jones, founder and managing partner of The Deerborne Group, framed the shift succinctly: “AI isn’t eliminating the need for consultants; it’s changing where consultants can add value.” He emphasized that as analysis becomes faster and more accessible, clients increasingly require expertise, judgment, and people who know how to execute—not simply more analysis. This quote captures the core insight that consulting’s future lies in the higher‑order skills that technology struggles to replicate.
The Deerborne Group’s Operator‑Led Model
Since 2020, The Deerborne Group has operated an operator‑led, network‑based consulting model built around experienced industry executives and subject‑matter experts rather than the traditional consulting pyramid. Unlike firms that rely on junior consultants to grind out research while senior partners oversee the process, Deerborne taps directly into seasoned professionals who have lived through the commercialization, regulatory, and market‑access challenges unique to genomics and precision diagnostics. This structure enables the firm to deliver judgment‑driven advice without the latency of a leveraged model.
Relevance to Genomics and Precision Diagnostics
The nuances of genomics and precision diagnostics amplify the need for expert judgment. Commercialization and go‑to‑market decisions in this sector intersect with clinical evidence, regulatory strategy, reimbursement, market access, laboratory operations, and investor expectations. As the report states, “Analysis is one challenge; knowing what matters, and how to execute, is another.” While AI can rapidly assess genomic trial data or simulate pricing scenarios, it cannot yet weigh the subtle trade‑offs between, for example, pursuing a breakthrough therapy with uncertain reimbursement versus a incremental innovation with clearer market pathways.
Future Outlook for Consulting Firms
Looking ahead, AI will continue to make strategy faster, automating routine analytical tasks and providing real‑time dashboards. The opportunity for consulting firms, therefore, lies less in producing analysis and more in providing what technology cannot easily replicate: deep domain expertise, sound judgment, and execution capability. Firms that reposition themselves as strategic partners—offering change‑management guidance, implementation support, and nuanced insight into industry‑specific dynamics—will capture the next wave of value in an AI‑augmented market.
About The Deerborne Group
The Deerborne Group is an operator‑led strategy and management consulting firm focused exclusively on genomics and precision diagnostics. Founded by diagnostics executive Jeffrey G. Jones, the firm advises Fortune 500 and emerging growth companies, boards, venture capital firms, and private‑equity investors on corporate and commercial strategy, clinical evidence, reimbursement and market access, operational execution, and investment diligence. Its niche focus allows it to bring deep, sector‑specific knowledge to every engagement, a critical advantage as AI reshapes the consulting landscape.
Conclusion
The Deerborne Group’s research underscores a fundamental transition in management consulting: the commoditization of analytical work through AI is pushing the industry toward higher‑value activities that rely on human expertise. For genomics and precision diagnostics—fields where scientific complexity meets commercial uncertainty—this shift is especially pronounced. Consulting firms that embrace this evolution, leveraging seasoned operators to deliver judgment, insight, and execution, will not only survive the AI revolution but thrive within it. As Jones aptly put it, the future belongs to those who can combine rapid analytics with the wisdom to know “what matters, and how to execute.”
https://www.prnewswire.com/news-releases/as-ai-reshapes-consulting-expertise-and-execution-become-the-differentiators-302884731.html